Why Does Ozempic Cause Constipation?

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Constipation affects up to 25% of patients taking semaglutide during the first weeks of treatment. This gastrointestinal side effect occurs because semaglutide activates GLP-1 receptors in the gut, deliberately slowing the rate at which food moves through your digestive system—the same mechanism that reduces appetite and improves blood sugar control.

How Semaglutide Slows Digestive Movement

Semaglutide works by mimicking glucagon-like peptide-1, a natural hormone that signals fullness and regulates blood glucose. When semaglutide binds to GLP-1 receptors in the stomach and intestines, it delays gastric emptying—the process by which food leaves your stomach and enters the small intestine. This slower movement creates prolonged satiety, so you eat less and lose weight more effectively.

The medication also affects peristalsis, the wave-like muscle contractions that push food through your colon. By reducing the strength and frequency of these contractions, semaglutide can cause stool to move more slowly through your large intestine, leading to constipation. This effect is dose-dependent, meaning higher doses increase the likelihood of digestive slowdown.

Most patients experience constipation most noticeably during dose escalation—when your dose may need to go up over the first month of treatment. Your price won't change, but your body needs time to adapt to increased GLP-1 receptor activation.

Why Constipation Occurs During Weight Loss Therapy

Beyond medication effects, constipation during semaglutide treatment also results from reduced calorie and fluid intake. When you eat significantly less food, your colon receives less volume to process, which naturally slows bowel movements. Many patients also forget to increase water consumption proportionally to their medication dose, further concentrating stool and worsening constipation.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Dehydration is a major contributor that many patients overlook. Semaglutide reduces appetite for both food and beverages, so you may drink less water without realizing it. Combined with slower colonic transit, inadequate hydration creates the perfect environment for constipation to develop.

Evidence-Based Strategies to Prevent and Relieve Constipation

Clinical trials and patient data support several practical interventions: increase water intake to at least 3 liters daily, add high-fiber foods gradually (too much fiber too quickly can worsen bloating), and engage in light physical activity like walking for 20–30 minutes after meals. These behavioral modifications address both the medication effect and the reduced food intake that drive constipation.

Over-the-counter osmotic laxatives like polyethylene glycol (MiraLAX) and stool softeners like docusate are generally safe during semaglutide treatment and can provide relief without interfering with weight loss. Some patients benefit from magnesium supplements (which also have a gentle laxative effect) or psyllium husk fiber added to water. Always consult your healthcare provider before adding any supplement, especially if you have kidney or heart concerns.

Timing matters: spreading smaller meals throughout the day rather than eating one larger meal may help stimulate more frequent bowel movements. Some patients find that taking semaglutide on the same day each week (if using the weekly injection) allows them to anticipate constipation and time preventive measures accordingly.

When Constipation Improves and When to Seek Help

Most patients see constipation resolve or significantly improve within 4–8 weeks as their body adapts to semaglutide. During this adjustment period, the combination of hydration, dietary fiber, and gentle physical activity typically prevents severe symptoms. If constipation persists beyond 8 weeks or worsens despite preventive measures, your healthcare provider may adjust your dose or switch to an alternative compound like tirzepatide.

Red flags requiring immediate medical attention include severe abdominal pain, inability to pass stool for more than 3 days, signs of bowel obstruction (persistent vomiting, bloating, or lack of gas), or blood in your stool. These symptoms are rare but warrant professional evaluation to rule out serious complications. PlexusDx supports all 50 states with licensed 503A compounding pharmacies, and your provider can adjust your treatment plan if constipation becomes unmanageable.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is constipation a sign that semaglutide is working?

Constipation indicates that semaglutide is activating GLP-1 receptors and slowing gastric emptying—the mechanism behind appetite suppression and weight loss. However, constipation is a side effect, not a sign of efficacy. Effective weight loss can occur without significant constipation if you manage hydration and fiber intake proactively.

Does compounded semaglutide cause constipation differently than brand-name Ozempic?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Ozempic and causes constipation through identical mechanisms. The main difference is that PlexusDx semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), offering significant cost savings without compromising safety or efficacy.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test ($298) analyzes variants like GIPR rs1800437 that influence how your body responds to semaglutide. This 14-pathway analysis of 49 peptides can identify genetic predispositions to GLP-1 sensitivity, helping your provider anticipate constipation risk and implement preventive strategies earlier.

Should I stop taking semaglutide if I develop constipation?

No—stopping semaglutide is not recommended without medical guidance. Constipation is manageable through hydration, fiber, laxatives, and physical activity. If symptoms become severe despite these interventions, contact your healthcare provider to discuss dose adjustments or alternative medications like oral semaglutide or tirzepatide, rather than discontinuing treatment.

Does oral semaglutide cause constipation like the injection?

Oral semaglutide ($289/mo at PlexusDx) activates the same GLP-1 receptors and causes constipation through the same mechanism as injections. However, some patients report slightly fewer gastrointestinal side effects with the oral form, possibly due to lower and more gradual absorption. Individual responses vary based on genetics and lifestyle factors.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.